Teva announces generic injection of Kytril

IRVINE, Calif. Following yesterday’s announcement of a generic pill form of Kytril, Teva is announcing the availability of a generic injection form of Kytril.

The drug is used for the prevention of nausea and vomiting associated with initial and repeated courses of chemotherapy.

Granisetron hydrochloride injection is available in 0.1 mg/mL, 0.1 mg, 1 mg/mL, and 1 mg in single dose glass vials.

“Teva’s commitment to new product development assures important new products like granisetron are available on a timely basis,” according to Jonathan Zalk, Teva’s director of marketing.